| Rizwan Tariq, MD | |
|
2545 Schoenersville Rd Fl 3, Bethlehem, PA 18017-7300 | |
| (484) 884-5733 | |
| (484) 884-5775 |
| Full Name | Rizwan Tariq |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 17 Years |
| Location | 2545 Schoenersville Rd Fl 3, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174836191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | MD449577 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lehigh Valley Physician Group | 3072425123 | 1763 |
News Archive
Men with increased body mass index (BMI) were significantly more likely to be infertile than normal-weight men, according to research conducted at the National Institute of Environmental Health Sciences (NIEHS).
Everyday we shed the outermost layer of our skin and replace it from within with new skin cells. Scientists from Cambridge have looked at the way that skin is renewed.
Finding a drug that targets only the diseased cells in our body and is otherwise harmless to healthy tissue is a goal for cancer researchers. It's driven the work of Professor Laurence Patterson, Director of the Institute of Cancer Therapeutics at the University of Bradford, and his team of researchers.
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
› Verified 3 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
Men with increased body mass index (BMI) were significantly more likely to be infertile than normal-weight men, according to research conducted at the National Institute of Environmental Health Sciences (NIEHS).
Everyday we shed the outermost layer of our skin and replace it from within with new skin cells. Scientists from Cambridge have looked at the way that skin is renewed.
Finding a drug that targets only the diseased cells in our body and is otherwise harmless to healthy tissue is a goal for cancer researchers. It's driven the work of Professor Laurence Patterson, Director of the Institute of Cancer Therapeutics at the University of Bradford, and his team of researchers.
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rizwan Tariq, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: (484) 884-4500 | Rizwan Tariq, MD 2545 Schoenersville Rd Fl 3, Bethlehem, PA 18017-7300 Ph: (484) 884-5733 |
News Archive
Men with increased body mass index (BMI) were significantly more likely to be infertile than normal-weight men, according to research conducted at the National Institute of Environmental Health Sciences (NIEHS).
Everyday we shed the outermost layer of our skin and replace it from within with new skin cells. Scientists from Cambridge have looked at the way that skin is renewed.
Finding a drug that targets only the diseased cells in our body and is otherwise harmless to healthy tissue is a goal for cancer researchers. It's driven the work of Professor Laurence Patterson, Director of the Institute of Cancer Therapeutics at the University of Bradford, and his team of researchers.
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
› Verified 3 days ago
Ashokkumar H Gaba, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2649 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Kathryn Mae Pisarcik, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd Fl 2, Bethlehem, PA 18017 Phone: 484-884-9677 Fax: 484-884-9297 | |
Dr. Minh Quang Nguyen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2300 Highland Ave, Bethlehem, PA 18020 Phone: 610-402-3110 | |
Dr. Jonathan H Munves, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2597 Schoenersville Rd, Suite 302, Bethlehem, PA 18017 Phone: 610-691-6222 Fax: 484-403-4011 | |
Dr. Anna Alina Niewiarowska, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 306 S New St Ste 201, Bethlehem, PA 18015 Phone: 610-866-0113 Fax: 610-974-8589 | |
Gonzalo Pimentel, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Jeffrey Faidley, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 |